New drug combo shows promise in rapidly easing suicidal urges
NCT ID NCT04116528
First seen Jun 01, 2026 · Last updated Jun 13, 2026 · Updated 4 times
Summary
This study looked at whether adding buprenorphine to ketamine treatment can reduce suicidal thoughts faster and longer than ketamine alone in people with major depression. About 50 adults participated. The main goal was to measure changes in suicidal thinking over one month. Results could offer a faster way to help those in crisis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University School of Medicine
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.